Ionetix Corporation Revenue and Competitors

Location

$85M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ionetix Corporation's estimated annual revenue is currently $14.9M per year.(i)
  • Ionetix Corporation's estimated revenue per employee is $232,406
  • Ionetix Corporation's total funding is $85M.

Employee Data

  • Ionetix Corporation has 64 Employees.(i)
  • Ionetix Corporation grew their employee count by 3% last year.

Ionetix Corporation's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VPReveal Email/Phone
3
COOReveal Email/Phone
4
VP AdministrationReveal Email/Phone
5
VP, Cardiology/Market AccessReveal Email/Phone
6
VP, Cyclotron R&DReveal Email/Phone
7
VP AdministrationReveal Email/Phone
8
VP Medical AffairsReveal Email/Phone
9
VP Sales & MarketingReveal Email/Phone
10
VP, Site OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M542-3%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M1634-2%N/AN/A
#10
$10.5M4812%N/AN/A
Add Company

What Is Ionetix Corporation?

Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. We are changing the paradigm when it comes to access to one of the most accurate PET imaging agents for the detection of coronary artery disease, N-13 Ammonia. Until now, this tracer was only available to a select group of institutions due to its very short half-life and the need for a large and expensive cyclotron on site. Ionetix can now provide virtually any hospital or private center with on demand N-13 Ammonia doses without the need to purchase a cyclotron!

keywords:N/A

$85M

Total Funding

64

Number of Employees

$14.9M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14M647%$410.5M
#2
$15M642%$1.4B
#3
$8.4M643%N/A
#4
$15M6419%N/A
#5
$9M64-6%$4.5M